Cellectar Biosciences announced today it has entered into definitive agreements with institutional investors to purchase approximately $5 million in a registered direct offering of 1,982,000 common shares and approximately $5…
SHINE has entered into an intellectual property license agreement with the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), the company announced today. According to a release,…
SHINE Medical Technologies broke ground today on a 43,000-square foot production facility, which sits on the land recently donated by the city of Janesville, the company announced today. “Construction of…
Nimble Therapeutics announced today that it has spun out from F. Hoffman-La Roche as a standalone biotech company. According to a release, Nimble Therapeutics will commercialize its proprietary chemical synthesis technology for…
Phoenix has secured $4 million in funding from the U.S. Army to demonstrate neutron-based methods of nondestructive testing, the company announced today. “With N-ray and X-ray capabilities merged, the technology Phoenix…
NorthStar Medical Technologies has closed $100 million in secured financing, the company announced recently. According to a release, the funds were managed by Oberland Capital Management, and the money will…
Imbed Biosciences, a medical device company that is developing advanced therapies for soft tissue repair, has closed a $2 million Series A funding round, the company announced recently. According to…
SHINE Medical Technologies was given a 91-acre parcel on the south side of Janesville for the company’s U.S. medical isotope production facility, the company announced recently. “This transfer represents the…
Promega announced recently that it launched a new tool called Water-Glo System that can be used for monitoring microbial contamination in freshwater, process water, seawater or wastewater samples. According to…
BioForward hosted the first Wisconsin event that collected genomics data, the organization announced recently. According to a release, BioForward partnered with keynote speaker Dr. Chris Mason, Associate Professor of Weill Cornell…
